| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR | RVI BIOTECNOLOGÍA | 35,510000 | 21/08/2026 | 25,26% | 109,01% | **** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 43,740000 | 21/08/2026 | 24,54% | 112,64% | ***** |
| PICTET - BIOTECH Z EUR | RVI BIOTECNOLOGÍA | 1.976,940000 | 21/08/2026 | 24,51% | · | ND |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 3.457,510000 | 21/08/2026 | 24,47% | 83,54% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 348,980000 | 21/08/2026 | 24,34% | 86,28% | *** |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR HEDGED | RVI BIOTECNOLOGÍA | 41,410000 | 21/08/2026 | 24,09% | 112,90% | **** |
| POLAR CAPITAL BIOTECHNOLOGY I EUR DIS HEDGED | RVI BIOTECNOLOGÍA | 15,460000 | 21/08/2026 | 24,08% | · | ND |
| JANUS HENDERSON HF - BIOTECHNOLOGY H2 EUR HEDGED | RVI BIOTECNOLOGÍA | 34,600000 | 21/08/2026 | 23,93% | 115,98% | **** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 20,830000 | 21/08/2026 | 23,91% | 107,26% | **** |
| PICTET - BIOTECH I USD | RVI BIOTECNOLOGÍA | 1.711,248825 | 21/08/2026 | 23,78% | 102,10% | **** |
| PICTET - BIOTECH I EUR | RVI BIOTECNOLOGÍA | 1.714,640000 | 21/08/2026 | 23,72% | 102,00% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | RVI BIOTECNOLOGÍA | 328,440000 | 21/08/2026 | 23,67% | 81,66% | *** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 88,887939 | 21/08/2026 | 23,62% | 33,81% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 121,369348 | 21/08/2026 | 23,59% | 33,65% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 120,035901 | 21/08/2026 | 23,58% | 32,38% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 98,239166 | 21/08/2026 | 23,50% | 33,28% | ** |
| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR HEDGED | RVI BIOTECNOLOGÍA | 33,650000 | 21/08/2026 | 23,49% | 111,64% | **** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 70,322250 | 21/08/2026 | 23,49% | 32,12% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 87,150000 | 21/08/2026 | 23,48% | 33,38% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | RVI BIOTECNOLOGÍA | 97,303607 | 21/08/2026 | 23,30% | 31,62% | ** |
